New Translational Imaging Center Opens - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

New Translational Imaging Center Opens



MPI Research, inviCRO, and 3D Imaging, have opened its new Translational Imaging Center at the global headquarters of MPI Research in Mattawan, Mich. The facility will be used to accelerate pharmaceutical discovery and development of new and improved therapeutics. The 10,000 sq ft, two-story facility features the first commercially available cyclotron (pictured at left), which provides new opportunities for scientists to accelerate the drug development process through the utilization of radioisotopes in molecular imaging to track distribution and efficacy of drug candidates.

The partnership between MPI Research, inviCRO, and 3D Imaging offers a combination of translational equipment and expertise to generate the images and data sets needed to enhance drug development decisions. MPI Research provides contract research services, while inviCRO provides a range of imaging services and software solutions. 3D Imaging operates the cyclotron, bringing new radiochemistry to drug development research.

The three organizations began the project in September 2013, and the cyclotron arrived in February 2014.

Source: MPI Research

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerRelationship-building at Top of Mind for Clients
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerRisk Reduction Top Driver for Biopharmaceutical Raw Material Development
Jill Wechsler Regulatory Watch Jill Wechsler Changes and Challenges for Generic Drugs
Faiz Kermaini Industry Insider Faiz KermainiNo Signs of a Slowdown in Mergers
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Better Comms Means a Fitter Future for Pharma, Part 1: Challenges and Changes
Sandoz Wins Biosimilar Filing Race
NIH Translational Research Partnership Yields Promising Therapy

Click here